Columbia Integrated Small Cap Growth Fund class I3
Columbia Integrated Small Cap Growth Fund class I3 (ISGQX)
The Columbia Integrated Small Cap Growth Fund class I3 (ISGQX) is a mutual fund that focuses on investing in small-cap companies with strong growth potential. This fund is managed by Columbia Threadneedle Investments and aims to provide long-term capital appreciation by investing in a diversified portfolio of small-cap stocks. With a focus on integration, this fund combines fundamental research with quantitative analysis to identify promising small-cap companies. As a class I3 fund, it is designed for institutional investors and has a lower expense ratio compared to other classes. Overall, ISGQX offers investors the opportunity to participate in the growth potential of small-cap companies while also providing diversification and professional management.
ISGQX Mutual Fund Chart & Stats
- Previous Close
- $13.78
- Sub-Category
- Small Cap
- Total Liabilities
- $32.62K
- Expense Ratio
- 0.85%
- Holding Count
- 133
- Brand
- Columbia Funds Series Trust Ii
- Category
- Equity
- Total Assets
- 23.12M
- Shares Outstanding
- N/A
- 52-Week Range
- $13.78 - $13.78
ISGQX Mutual Fund News
Vaxcyte Study Update: VAX-31 Trial Completion Sets Up a Key Data Catalyst
Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: The official title is A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability,
Vaxcyte’s VAX-31 Study Reaches Completion, but Investors Await Results
Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: Vaxcyte’s Phase 3 study, officially titled “A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the
ISGQX Mutual Fund Smart Score
Top 10 Holdings
Recently Viewed
No data currently available






